Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Shares Outstanding (Weighted Average) (2016 - 2025)

Biomerica's Shares Outstanding (Weighted Average) history spans 13 years, with the latest figure at $2.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 35.88% year-over-year to $2.9 million; the TTM value through Nov 2025 reached $2.9 million, up 35.88%, while the annual FY2025 figure was $2.3 million, 9.22% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $2.9 million at Biomerica, up from $2.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $19.2 million in Q1 2025 and bottomed at $2.1 million in Q2 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $12.6 million (2021), against an average of $10.6 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) plummeted 87.5% in 2024 before it surged 35.88% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $12.6 million in 2021, then rose by 6.85% to $13.5 million in 2022, then increased by 25.02% to $16.8 million in 2023, then tumbled by 87.28% to $2.1 million in 2024, then surged by 35.88% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Shares Outstanding (Weighted Average) are $2.9 million (Q4 2025), $2.6 million (Q3 2025), and $2.3 million (Q2 2025).